Ferring has a total of 89 patents globally, out of which 45 have been granted. Of these 89 patents, more than 24% patents are active. United States of America is where Ferring has filed the maximum number of patents, followed by Russia and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also Switzerland is the origin country of Ferring.
Ferring was founded in the year 1950. The Company’s mission is to help patients by researching, developing, manufacturing and marketing the most effective and innovative products in reproductive health, women’s health, urology, gastroenterology, endocrinology and orthopedics.
Do read about some of the most popular patents of Ferring which have been covered by us in this article and also you can find Ferring patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ferring patent portfolio.
How many patents does the founder of Ferring have?
The founder Frederik Paulsen has 6 patents.
How many patents does Ferring have?
Ferring has a total of 89 patents globally. These patents belong to 33 unique patent families. Out of 89 patents, 22 patents are active.
How Many Patents did Ferring File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Ferring Applications Filed | Ferring Patents Granted |
| 2022 | 3 | 5 |
| 2021 | 1 | – |
| 2020 | – | 1 |
| 2019 | – | 2 |
| 2018 | 2 | 1 |
| 2017 | – | 1 |
| 2015 | 1 | 2 |
| 2014 | 3 | 5 |
| 2013 | – | 4 |
| 2012 | 2 | 3 |
| 2011 | 2 | 3 |
Which Ferring Drug Patents are Expiring in the Next 10 Years?
The patent no. US10695398B2 which is expiring in Apr, 2032, describes treating prostate cancer with reduced side effects involves giving an initial dose of 160-320 mg of degarelix, followed by a maintenance dose of 60-160 mg every 20-36 days. This approach minimizes the risk of testosterone spikes and other side effects associated with GnRH agonist therapy.
Given below is the list of few drugs patented by Ferring accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Firmagon | US10695398B2 | Method Of Treating Prostate Cancer… | Apr, 2032 |
| Nocdurna | US9974826B2 | Methods Comprising Desmopressin | Apr, 2030 |
| Milprosa | US8580293B2 | Monolithic Intravaginal Rings… | Jan, 2030 |
| Prepopik | US8481083B2 | Granular Compositions Of Magnesi… | Oct, 2028 |
Interested in knowing about Ferring’s Drug Patents Expiring in the next 10 years?
How many Ferring patents are Alive/Dead?
How Many Patents did Ferring File in Different Countries?
Countries in which Ferring Filed Patents
| Country | Patent |
| United States Of America | 21 |
| Russia | 13 |
| Europe | 9 |
| Japan | 6 |
| Australia | 6 |
| Eurasia | 6 |
| China | 4 |
| Canada | 4 |
| Germany | 3 |
| United Kingdom | 2 |
| New Zealand | 1 |
| Austria | 1 |
| Israel | 1 |
Where are Research Centres of Ferring Patents Located?
10 Best Ferring Patents
US6921811B2 is the most popular patent in the Ferring portfolio. It has received 208 citations so far from companies like Ension, Cythera and Novocell.
Below is the list of 10 most cited patents of Tate & Lyle:
| Publication Number | Citation Count |
| US6921811B2 | 208 |
| WO2002003890A1 | 201 |
| US6613432B2 | 180 |
| US6342591B1 | 127 |
| US6596699B2 | 61 |
| US7528105B1 | 48 |
| WO2006093808A1 | 39 |
| US20040058056A1 | 37 |
| US7217769B2 | 33 |
| US20020055667A1 | 31 |